Allient (ALNT) CEO Richard Warzala receives new time- and performance-based stock awards

Rhea-AI Filing Summary

WARZALA RICHARD S reported acquisition or exercise transactions in this Form 4 filing.

Allient Inc. Chief Executive Officer Richard S. Warzala reported equity awards of common stock on March 5, 2026. He received 18,850 time-based restricted shares that vest in three equal installments on April 1, 2027, 2028 and 2029. He also received 15,709 performance-based restricted shares that may vest over three years if performance goals for the year ending December 31, 2026 are met, and 3,617 performance-based restricted shares that were earned for goals for the year ended December 31, 2025 and vest one-third on April 1, 2026, 2027 and 2028. After these awards, his directly held common stock increased to 1,592,062 shares, with an additional 26,067 shares held indirectly through an ESOP trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WARZALA RICHARD S

(Last) (First) (Middle)

ALLIENT INC.

495 COMMERCE DRIVE

(Street)

AMHERST NY 14228

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLIENT INC [ ALNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		18,850(1)	A	$62.07	1,572,736	D
Common Stock	03/05/2026		A		15,709(2)	A	$62.07	1,588,445	D
Common Stock	03/05/2026		A		3,617(3)	A	$62.07	1,592,062	D
Common Stock								26,067	I	By ESOP Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.

2. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.

3. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.

	/s/ Michael C. Donlon, Attorney-in-Fact for Richard S. Warzala	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Allient (ALNT) CEO Richard Warzala report on March 5, 2026?

He reported equity awards of Allient common stock, not open-market trades. The filing shows three grants of restricted shares, including time-based and performance-based awards, increasing his directly held stake to 1,592,062 shares plus ESOP-held shares.

How many time-based restricted Allient (ALNT) shares were granted to the CEO?

Richard Warzala received 18,850 time-based restricted shares of Allient common stock. These shares were granted under the 2017 Omnibus Incentive Plan and will vest in three equal installments on April 1, 2027, April 1, 2028 and April 1, 2029.

What performance-based restricted Allient (ALNT) shares did the CEO receive tied to 2026 goals?

He was granted 15,709 performance-based restricted shares linked to goals for the year ending December 31, 2026. All or part of these shares may vest over a three-year period if Compensation Committee performance targets set for 2026 are satisfied.

What performance-based Allient (ALNT) shares were earned by the CEO for 2025 performance?

The filing reports 3,617 performance-based restricted shares earned based on goals for the year ended December 31, 2025. These shares vest in three equal installments on April 1, 2026, April 1, 2027 and April 1, 2028 under the company’s incentive plan.

What is Richard Warzala’s Allient (ALNT) share ownership after these awards?

After the reported grants, Richard Warzala directly holds 1,592,062 shares of Allient common stock. The Form 4 also lists 26,067 additional shares held indirectly through an ESOP trust, reflecting separate indirect ownership associated with his position.

At what reference price were the reported Allient (ALNT) awards valued per share?

Each reported grant of Allient common stock uses a reference price of $62.07 per share. This per-share figure appears consistently across the three restricted stock awards disclosed in the Form 4 insider transaction details.